Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Rhee, Soo-YonVarghese, ViciHolmes, Susan P.Van Zyl, Gert U.Steegen, KimBoyd, Mark A.Cooper, David A.Nsanzimana, SabinSaravanan, ShanmugamCharpentier, CharlotteOliveira, Tulio deEtiebet, Mary-Ann A.Garcia, FedericoGoedhals, DominiqueGomes, PerpétuaGünthard, Huldrych F.Hamers, Raph L.Hoffmann, Christopher J.Hunt, GillianJiamsakul, AwachanaKaleebu, PontianoKanki, PhyllisKantor, RamiKerschberger, BernhardMarconi, Vincent C.Ndahimana, Jean D'amourNdembi, NicaiseNgo-Giang-Huong, NicoleRokx, CasperSantoro, Maria M.Schapiro, Jonathan M.Schmidt, DanielSeu, LillianSigaloff, Kim C. E.Sirivichayakul, SuneeSkhosan, LindiweSunpath, HenryTang, MicheleYang, ChunfuCarmona, SergioGupta, Ravindra K.Shafer, Robert W.2019-12-202019-12-202017-04EBioMedicine. 2017 Apr;18:225-235. doi: 10.1016/j.ebiom.2017.03.024http://hdl.handle.net/10400.26/30655This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).engHIV-1Antiretroviral therapyReverse transcriptaseDrug resistanceTenofovirWHO-recommended first-lineMutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaborationjournal article10.1016/j.ebiom.2017.03.024